Breaking News, Collaborations & Alliances

VivaMed, Syngene Collaborate on AI-Powered Validation Infrastructure Expansion

Syngene’s preclinical development capabilities will be called upon to integrate with VivaMed’s AI-derived therapeutic hypotheses.

Author Image

By: Patrick Lavery

Content Marketing Editor

VivaMed BioPharma and CRDMO Syngene International are partnering on artificial intelligence (AI)-powered discovery to bolster VivaMed’s validation infrastructure. As a clinical-stage pharmaceutical company, VivaMed uses AI for discovery and advancement of repurposed and improved therapeutic assets. Accordingly, the collaboration with Syngene aims to expand VivaMed’s validation infrastructure. The eventual goal is to deliver scientifically validated and partner-ready therapeutic programs. H...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters